CTRC

San Antonio, Texas 78258

0 studies enrolling now · 3 studies all time

What they study most

Bone Metastases, Multiple Myeloma, Prostate Cancer, Solid Tumor Malignancies, Cancer

Studies at this site

• Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma — Stopped early
• A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases — Stopped early
• An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies — Completed